Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
Moomoo > Quotes > XLO Xilio Therapeutics > Detailed Quotes

XLO Xilio Therapeutics

Watchlist
3.380
-0.190-5.32%
Close  02/08 16:00 ET
3.3800.0000.00%
Post Mkt Price 02/08 17:01 ET
High
3.550
Open
3.550
Turnover
114.16K
Low
3.261
Pre Close
3.570
Volume
33.87K
Market Cap
92.85M
P/E(TTM)
Loss
52wk High
14.860
Shares
27.47M
P/E(Static)
Loss
52wk Low
1.950
Float Cap
36.06M
Bid/Ask %
0.00%
Historical High
27.950
Shs Float
10.67M
Volume Ratio
1.11
Historical Low
1.950
Dividend TTM
--
Div Yield TTM
--
P/B
0.74
Dividend LFY
--
Div Yield LFY
--
Turnover Ratio
0.32%
Amplitude
8.08%
Avg Price
3.370
Lot Size
1
Float Cap
36.06M
Bid/Ask %
0.00%
Historical High
27.950
Shs Float
10.67M
Volume Ratio
1.11
Historical Low
1.950
Dividend TTM
--
P/B
0.74
Dividend LFY
--
Turnover Ratio
0.32%
Amplitude
8.08%
Avg Price
3.370
Lot Size
1
Price Forecast

News

Comment

Company Overview More
Xilio Therapeutics, Inc. operates as a biotechnology company. It focuses on harnessing the immune system to achieve deep and durable clinical responses in cancer. The company uses its proprietary geographically precise solutions platform to rapidly engineer novel molecules, including cytokines and other biologics. Xilio Therapeutics was founded by John C. Williams and Ulrich Rodeck in June 2015 and is headquartered in Waltham, MA.
CEO: Dr. Rene Russo, Pharm.D.
Market: NASDAQ
Listing Date: 10/22/2021
Paper Trade More
Direction
Buy
Sell
Types
LMT Order
Price
QTY
Amount
--
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist